Literature DB >> 16196390

Excitotoxicity in perinatal brain injury.

Michael V Johnston1.   

Abstract

Excitotoxicity is an important mechanism involved in perinatal brain injuries. Glutamate is the major excitatory neurotransmitter, and most neurons as well as many oligodendrocytes and astrocytes possess receptors for glutamate. Perinatal insults such as hypoxia-ischemia, stroke, hypoglycemia, kernicterus, and trauma can disrupt synaptic function leading to accumulation of extracellular glutamate and excessive stimulation of these receptors. The activities of certain glutamate receptor/channel complexes are enhanced in the immature brain to promote activity-dependent plasticity. Excessive stimulation of glutamate receptor/ion channel complexes triggers calcium flooding and a cascade of intracellular events that results in apoptosis and/or necrosis. Recent research suggests that some of these intracellular pathways are sexually dimorphic. Age dependent expression of different glutamate receptor subtypes with varying abilities to flux calcium has been associated with special patterns of selective vulnerability at different gestational ages. For example, selective injury to the putamen, thalamus and cerebral cortex from near total asphyxia in term infants may be related to excessive activation of neuronal NMDA and AMPA type glutamate receptors, while brainstem injury may be related primarily to stimulation of neuronal AMPA/kainate receptors. In contrast, periventricular leukomalacia in premature infants has been linked to expression of AMPA/kainate receptors on immature oligodendrocytes. Insight into the molecular pathways that mediate perinatal brain injuries could lead to therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16196390     DOI: 10.1111/j.1750-3639.2005.tb00526.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  86 in total

Review 1.  Protecting motor networks during perinatal ischemia: the case for delta-opioid receptors.

Authors:  Stephen M Johnson; Sara M F Turner
Journal:  Ann N Y Acad Sci       Date:  2010-06       Impact factor: 5.691

2.  The effects of therapeutic hypothermia on cerebral metabolism in neonates with hypoxic-ischemic encephalopathy: An in vivo 1H-MR spectroscopy study.

Authors:  Jessica L Wisnowski; Tai-Wei Wu; Aaron J Reitman; Claire McLean; Philippe Friedlich; Douglas Vanderbilt; Eugenia Ho; Marvin D Nelson; Ashok Panigrahy; Stefan Blüml
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-02       Impact factor: 6.200

Review 3.  Modeling Ischemia in the Immature Brain: How Translational Are Animal Models?

Authors:  Carina Mallard; Zinaida S Vexler
Journal:  Stroke       Date:  2015-08-13       Impact factor: 7.914

4.  Genetic program of neuronal differentiation and growth induced by specific activation of NMDA receptors.

Authors:  Cristina A Ghiani; Luis Beltran-Parrazal; Daniel M Sforza; Jemily S Malvar; Akop Seksenyan; Ruth Cole; Desmond J Smith; Andrew Charles; Pedro A Ferchmin; Jean de Vellis
Journal:  Neurochem Res       Date:  2006-12-27       Impact factor: 3.996

5.  Selective vulnerability and the cerebellum in neonates.

Authors:  Mauricio Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

Review 6.  Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns.

Authors:  Jon F Watchko
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

7.  Effect of resuscitation with 21% oxygen and 100% oxygen on NMDA receptor binding characteristics following asphyxia in newborn piglets.

Authors:  David Joseph Hoffman; Eric Lombardini; Om Prakash Mishra; Maria Delivoria-Papadopoulos
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

8.  Differing intrinsic biological properties between forebrain and spinal oligodendroglial lineage cells.

Authors:  Makoto Horiuchi; Yoko Suzuki-Horiuchi; Tasuku Akiyama; Aki Itoh; David Pleasure; Earl Carstens; Takayuki Itoh
Journal:  J Neurochem       Date:  2017-06-09       Impact factor: 5.372

Review 9.  Hyperphosphorylated tau is implicated in acquired epilepsy and neuropsychiatric comorbidities.

Authors:  Ping Zheng; Sandy R Shultz; Chris M Hovens; Dennis Velakoulis; Nigel C Jones; Terence J O'Brien
Journal:  Mol Neurobiol       Date:  2013-12-10       Impact factor: 5.590

Review 10.  Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration.

Authors:  Juan A Orellana; Pablo J Sáez; Kenji F Shoji; Kurt A Schalper; Nicolás Palacios-Prado; Victoria Velarde; Christian Giaume; Michael V L Bennett; Juan C Sáez
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.